SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today introduced an enhanced version of SureDesign software enabling clinical researchers to design customized CGH (comparative genomic hybridization), ChIP-on-chip (chromatin immunoprecipitation), and DNA methylation microarrays for molecular cytogenomics and other applications. The new version of SureDesign replaces these microarray applications for the eArray platform and provides […]
Louvain-la-Neuve, Belgium – IBA (Ion Beam Applications S.A., EURONEXT), the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces the closing of the sale of 100% of its Business Unit Cisbio Bioassays. Today’s closing has led to a payment to IBA of EUR 16.3 million. In addition, the contract includes […]
SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today introduced the latest version of its electronic laboratory notebook (ELN) software, OpenLAB ELN 4.2. This newly enhanced software enables scientists and laboratory managers to quickly and easily capture, reuse, manage and share scientific results obtained from virtually any analytical software application. “With this new revision, […]
NEWARK, Calif. — StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing novel cell-based therapeutics for disorders of the central nervous system, today announced that Greg Schiffman will join its executive team as Chief Financial Officer and Executive Vice President of Finance, effective January 1, 2014. In his new role, Mr. Schiffman will be responsible […]
St. Cloud, Minnesota, USA — Microbiologics, a leading global manufacturer of prepared quality control microorganism products, debuts its first molecular product line, Helix Elite™. These molecular standards are intended to facilitate the development, validation, and monitoring of molecular assays. The Helix Elite™ molecular product line currently includes 13 molecular standards for microorganisms that are difficult […]
Jena, Germany — Endress+Hauser (Deutschland) AG Co. KG (“E+H KG”) concluded an option agreement with the founder and Chief Executive Officer of Analytik Jena AG, Klaus Berka, and with the Thüringer Industriebeteiligungs-GmbH & Co. KG (“TIB”) today. Through it, the contract parties have the right to purchase or transfer the shares of Analytik Jena AG […]
CINCINNATI — Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc. (NASDAQ:VIVO), is proud to announce the worldwide release of the MyTaqTM Blood-PCR Kit, developed for fast, highly-specific PCR direct from whole blood samples. Based on the proven MyTaqTM HS DNA polymerase, in combination with a novel, red-colored, buffer system; the new Bioline […]
Las Vegas, NV — Station X has created GenePool, a new software platform that allows medical researchers to solve complex biological and clinical problems. The GenePool software-as-a-service platform empowers researchers to analyze large clinical populations and expedite diagnostic development and research into genetic diseases. With GenePool, researchers in Pharma and Biotech companies can shave months […]
FREMONT, Calif. — WaferGen Bio-systems, Inc. (OTCQB: WGBS) announced today its financial results for the third quarter ended September 30, 2013. Total revenue for the third quarter of 2013 was $390,000, up 121% from $177,000 in the third quarter of 2012. Net loss for the third quarter of 2013 was $11.0 million, compared to a […]
PLANEGG, Germany — Biomax Informatics AG will invest nearly 1 million Euro over the next 4 years to transfer its successful systems medicine approach from respiratory and chronic diseases to mental health. The European Commission is co-financing this step with €650,000 as part of the METSY project. In the project, Biomax will provide the knowledge […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
